University Health System researchers discovered they could prevent diabetes from recurring in diabetic mice by transplanting insulin-manufacturing islet cells and then administering an anti-inflammatory drug called Lisofylline, according to a University Health System press release.
Researchers knew that transplantation was promising in treating type 1 diabetes. But the body destroyed islet cells without immune system-suppressing drugs.
The newly-created drug Lisofylline prevents cell destruction without the need for immune suppressants.
Researchers said their next step will be to test the drug in humans who have received islet cell transplants.
Read More
New Education Department letter urges university reforms — U.Va. professors weigh in
By Grace Little | YesterdayThe letter called on all postsecondary institutions to issue statements of allegiance to its educational mission and address questions regarding fair admissions criteria, open discourse, intellectual pluralism and affordability.
Amid pushback, City Council budgets $4 million toward encampment removal efforts
By Luca Bailey | 2 days agoThe Council also received a status update on the City’s efforts to clear the area.
Where does U.Va.'s DOJ agreement stand among five other university settlements?
By Naren Senthilkumar | 4 days agoColumbia University, Brown University, the University of Pennsylvania, Cornell University and Northwestern University all reached settlements with federal officials over the last year.
